Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Orion Healthcare Equity Partners

Founders Mark Carthy

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 2
Rounds per year 0.20
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees Soon
Stages of investment
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
Summary

Orion Healthcare Equity Partners is the famous VC, which was founded in 2007. The venture was found in North America in United States. The main department of described VC is located in the Boston.

The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Sanofi-Genzyme BioVentures, Roche Venture Fund, Pfizer Venture Investments. In the next rounds fund is usually obtained by Sanofi-Genzyme BioVentures, Roche Venture Fund, Partners Innovation Fund.

This organization was formed by Mark Carthy.

The high activity for fund was in 2016. The higher amount of exits for fund were in 2017. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline AnTolRx, Lysosomal Therapeutics Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Biotechnology.

Read more

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3 Wise Ventures Delaware, United States, Wilmington
Capital Fund Management France, Ile-de-France, Paris
Co-Share capital China, Guangdong, Guangzhou
eFund Seattle, United States, Washington
Enterprise Community Investment Columbia, Maryland, United States
Epic Labs Community of Madrid, Madrid, Spain
Fair4All Finance England, London, United Kingdom
HALL Group Dallas, Texas, United States
IMechE England, London, United Kingdom
Infuse Ventures Ahmedabad, Gujarat, India
Invision Capital Chicago, Illinois, United States
Luma Launch California, Santa Monica, United States
Lumar Ilford, Redbridge, United Kingdom
Machem Capital -
Misgav Technology Center HaZafon, Israel, Misgav
NHN JAPAN Japan, Tokyo
SZHTI Group China, Guangdong, Shenzhen
Tru Arrow Partners -
VisVires New Protein Central, Central Region, Singapore
Zhaogang.com China, Hainan, Yangpu

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AnTolRx

Biotechnology
Health Care
$4M08 Sep 2016 Cambridge, Massachusetts, United States

Lysosomal Therapeutics

Biotechnology
Health Care
Therapeutics
$20M03 Feb 2015 Cambridge, Massachusetts, United States

Lysosomal Therapeutics

Biotechnology
Health Care
Therapeutics
$4M12 May 2014 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Orion Healthcare Equity Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 9M
Rounds per year 0.20
Peak activity year 2016
Lead investments 0
Follow on index 0.33
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AnTolRx

Biotechnology
Health Care
$4M08 Sep 2016 Cambridge, Massachusetts, United States

Lysosomal Therapeutics

Biotechnology
Health Care
Therapeutics
$20M03 Feb 2015 Cambridge, Massachusetts, United States

Lysosomal Therapeutics

Biotechnology
Health Care
Therapeutics
$4M12 May 2014 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: